Nchi: Marekani
Lugha: Kiingereza
Chanzo: NLM (National Library of Medicine)
AMLODIPINE BESYLATE (UNII: 864V2Q084H) (AMLODIPINE - UNII:1J444QC288)
Hikma Pharmaceuticals USA Inc.
AMLODIPINE BESYLATE
AMLODIPINE 2.5 mg
ORAL
PRESCRIPTION DRUG
Amlodipine besylate tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including amlodipine besylate tablets. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than one drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC). Numerous antihypertensive drugs, from a variety of pharmacologic
2.5 mg Tablets Amlodipine besylate tablets, USP – 2.5 mg (amlodipine besylate equivalent to 2.5 mg of amlodipine per tablet) are white, diamond, shaped tablets engraved with "W59" on one side and supplied as follows: Bottles of 30 with Child-resistance closure, NDC 0143-9959-30 Bottles of 90 with Child-resistance closure, NDC 0143-9959-09 Bottles of 100 with Child-resistance closure, NDC 0143-9959-01 5 mg Tablets Amlodipine besylate tablets, USP – 5 mg (amlodipine besylate equivalent to 5 mg of amlodipine per tablet) are white, octagon shaped tablets engraved with "W60" on one side and supplied as follows: Bottles of 30 with Child-resistance closure, NDC 0143-9960-30 Bottles of 90 with Child-resistance closure, NDC 0143-9960-09 Bottles of 100 with Child-resistance closure, NDC 0143-9960-01 10 mg Tablets Amlodipine besylate tablets, USP – 10 mg (amlodipine besylate equivalent to 10 mg of amlodipine per tablet) are white, round tablets engraved with "W61" on one side and supplied as follows: Bottles of 30 with Child-resistance closure, NDC 0143-9961-30 Bottles of 90 with Child-resistance closure, NDC 0143-9961-90 Bottles of 100 with Child-resistance closure, NDC 0143-9961-01 Storage This package is child-resistant. Store bottles at 20° to 25°C (68° to 77°F) [ See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure. . Distributed by: West-Ward Pharmaceuticals Corp. Eatontown, NJ 07724 USA Manufactured by: HIKMA Pharmaceuticals LLC P.O. Box 182400 Amman 11118 Jordan Revised November 2019
Abbreviated New Drug Application
AMLODIPINE BESYLATE- AMLODIPINE BESYLATE TABLET West-Ward Pharmaceuticals Corp ---------- Medication Guide Amlodipine Besylate Tablets, USP Read this information carefully before you start taking Amlodipine Besylate Tablets, USP and each time you refill your prescription. There may be new information. This information does not replace talking with your doctor. If you have any questions about Amlodipine Besylate Tablets, USP ask your doctor. Your doctor will know if Amlodipine Besylate Tablets, USP is right for you. What are Amlodipine Besylate Tablets, USP? Amlodipine Besylate Tablets, USP are a type of medicine known as a calcium channel blocker (CCB). It is used to treat high blood pressure (hypertension) and a type of chest pain called angina. It can be used by itself or with other medicines to treat these conditions. High Blood Pressure (hypertension) High blood pressure comes from blood pushing too hard against your blood vessels. Amlodipine Besylate Tablets, USP relaxes your blood vessels, which lets your blood flow more easily and helps lower your blood pressure Drugs that lower blood pressure lower your risk of having a stroke or heart attack. Angina Angina is a pain or discomfort that keeps coming back when part of your heart does not get enough blood. Angina feels like a pressing or squeezing pain, usually in your chest under the breastbone. Sometimes you can feel it in your shoulders, arms, neck, jaws, or back. Amlodipine Besylate Tablets, USP can relieve this pain. Who should not use Amlodipine Besylate Tablets, USP? Do not use Amlodipine Besylate Tablets, USP if you are allergic to amlodipine (the active ingredient in Amlodipine Besylate Tablets, USP), or to the inactive ingredients. Your doctor or pharmacist can give you a list of these ingredients. What should I tell my doctor before taking Amlodipine Besylate Tablets, USP? Tell your doctor about any prescription and non-prescription medicines you are taking, including natural or herbal remedies. Tell your doctor if you: • ever had heart disease Soma hati kamili
AMLODIPINE BESYLATE- AMLODIPINE BESYLATE TABLET HIKMA PHARMACEUTICALS USA INC. ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE AMLODIPINE BESYLATE SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR AMLODIPINE BESYLATE. AMLODIPINE BESYLATE TABLETS, USP INITIAL U.S. APPROVAL: 1987 INDICATIONS AND USAGE Amlodipine besylate tablets, are a calcium channel blocker and may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of: • Hypertension (1.1) o Amlodipine besylate tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. • Coronary Artery Disease (1.2) o Chronic Stable Angina o Vasospastic Angina (Prinzmetal’s or Variant Angina) o Angiographically Documented Coronary Artery Disease in patients without heart failure or an ejection fraction < 40% DOSAGE AND ADMINISTRATION Adult recommended starting dose: 5 mg once daily with maximum dose 10 mg once daily. (2.1) o Small, fragile, or elderly patients, or patients with hepatic insufficiency may be started on 2.5 mg once daily. (2.1) Pediatric starting dose: 2.5 mg to 5 mg once daily. (2.2) IMPORTANT LIMITATION: Doses in excess of 5 mg daily have not been studied in pediatric patients. (2.2) DOSAGE FORMS AND STRENGTHS • Tablets: 2.5 mg, 5 mg, and 10 mg (3) CONTRAINDICATIONS Known sensitivity to amlodipine (4) WARNINGS AND PRECAUTIONS • Symptomatic hypotension is possible, particularly in patients with severe aortic stenosis. However, acute hypotension is unlikely. (5.1) • Worsening angina and acute myocardial infarction can develop after starting or increasing the dose of Amlodipine besylate tablets particularly in patients with severe obstructive coronary artery disease. (5.2) • Titrate slowly in patients with severe hepatic impairment. (5.3) ADVERSE REACTIONS Most common advers Soma hati kamili